deaths from semaglutide Recent study at UC Irvine found that medication may benefit 93 million U.S. adults FDA Warns Novo Over Unreported
Description
However, GLP-1s work best with a healthy diet and exercise plan

The goal was to help manage metabolic conditions like type 2 diabetes

Oral semaglutide must be taken on an empty stomach

Manufacturers augmented patent protection with a median of 2 regulatory exclusivities (IQR: 0-3) obtained at approval and 1 (IQR: 0.3-4.3) added after approval

This cardiovascular benefit was observed across diverse patient populations and appears to extend beyond glucose control effects
